Mentoring and Research in Cancer Palliative Care
癌症姑息治疗的指导和研究
基本信息
- 批准号:8312330
- 负责人:
- 金额:$ 19.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-02 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:Advanced Malignant NeoplasmAdverse eventAmericanAnorexiaBereavementBiolectric ImpedanceBody Weight decreasedCancer PatientClinicClinical ResearchClinical TrialsComprehensive Cancer CenterCreatineDesire for foodDiagnosisEnsureEnvironmentGoalsGrowthLaboratoriesMalignant NeoplasmsManuscriptsMentorsPatient CarePlacebosPublishingResearchResearch InfrastructureResearch PersonnelResourcesSeveritiesSymptomsTimeToxic effectTranslational ResearchTreatment-Related CancerWeightcancer anorexiacancer palliative treatmentcancer therapycareerend of lifemeetingssuccesstranslational study
项目摘要
DESCRIPTION (provided by applicant): Last year, approximately 1,400,000 Americans were diagnosed with cancer, and approximately 560,000 died from it. When one considers the adverse events associated with cancer treatment, the wide constellation and severity of end-of-life symptoms, and the aftermath of bereavement, there is no question that cancer-induced suffering is great and that there is a major need for research in cancer palliative care to relieve this suffering.
Dr. Jatoi is a mid-career investigator who is re-submitting a K24 application entitled, "Mentoring and Research in Cancer Palliative Care." Her career goals are as follows: 1) To conduct rigorous, clinical and translational research in cancer palliative care with the short-term goal of relieving suffering among cancer patients; 2) To provide opportunities for career growth in cancer palliative care for a diverse group of young investigators with the long-term goal of, again, relieving suffering among cancer patients.
Dr. Jatoi is well suited to meet these career goals. She has conducted multiple clinical and translational studies on cancer palliative care, thus generating over 120 published manuscripts. These studies have focused largely on palliating cancer-associated anorexia and weight loss, but they have also, at times, focused on the management of other cancer-related symptoms. As a mentor and senior author, Dr. Jatoi has published 28 manuscripts with 16 young investigators from highly diverse backgrounds. Finally, the Mayo Clinic Comprehensive Cancer Center holds an unwavering commitment to patient care, a vast clinical trial infrastructure, comprehensive laboratory resources, and a dynamic, highly collaborative environment- thus, further ensuring the success of this application.
描述(由申请人提供):去年,大约140万美国人被诊断出患有癌症,大约56万人死于癌症。当人们考虑到与癌症治疗相关的不良事件、临终症状的广泛和严重程度以及丧失亲人的后果时,毫无疑问,癌症引起的痛苦是巨大的,迫切需要研究癌症姑息治疗来缓解这种痛苦。
贾托博士是一名职业生涯中期的研究人员,他正在重新提交一份K24申请,标题为《癌症姑息治疗中的指导和研究》。她的职业目标如下:1)在癌症姑息治疗方面进行严谨的临床和转化性研究,短期目标是减轻癌症患者的痛苦;2)为不同的年轻研究人员提供癌症姑息治疗方面的职业发展机会,长期目标再次是减轻癌症患者的痛苦。
贾托博士非常适合实现这些职业目标。她进行了多项关于癌症姑息治疗的临床和翻译研究,从而产生了120多篇已发表的手稿。这些研究主要集中在缓解癌症相关的厌食症和减肥上,但有时也关注其他癌症相关症状的处理。作为导师和资深作者,贾托博士与来自不同背景的16名年轻研究人员一起发表了28篇手稿。最后,梅奥诊所综合癌症中心坚定不移地致力于患者护理、庞大的临床试验基础设施、全面的实验室资源以及动态、高度协作的环境-因此,进一步确保了这一应用的成功。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A systematic compilation of reports published on opioid-related problems.
关于阿片类药物相关问题的报告的系统汇编。
- DOI:10.5055/jom.2011.0047
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Butts,Matthew;Jatoi,Aminah
- 通讯作者:Jatoi,Aminah
Bevacizumab-induced nasal septal perforation: incidence of symptomatic, confirmed event(s) in colorectal cancer patients.
- DOI:10.3109/0284186x.2010.537692
- 发表时间:2011-05
- 期刊:
- 影响因子:0
- 作者:Ramiscal JA;Jatoi A
- 通讯作者:Jatoi A
Bone pain from granulocyte colony stimulating factor: does clinical trial sponsorship by a pharmaceutical company influence its reporting?
粒细胞集落刺激因子引起的骨痛:制药公司赞助的临床试验是否会影响其报告?
- DOI:10.1111/j.1365-2354.2009.01136.x
- 发表时间:2011
- 期刊:
- 影响因子:2.1
- 作者:Aldairy,Y;Nguyen,PL;Jatoi,A
- 通讯作者:Jatoi,A
Parenteral nutrition in patients with advanced cancer: merging perspectives from the patient and healthcare provider.
晚期癌症患者的肠外营养:患者和医疗保健提供者的观点融合。
- DOI:10.1053/j.seminoncol.2011.03.020
- 发表时间:2011
- 期刊:
- 影响因子:4
- 作者:Mitchell,Jessica;Jatoi,Aminah
- 通讯作者:Jatoi,Aminah
Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival.
292 名接受化疗的癌症患者对年龄的自我认知:探索与症状和生存的关联。
- DOI:10.1016/j.jgo.2013.02.001
- 发表时间:2013
- 期刊:
- 影响因子:3
- 作者:Lim,MingY;Stephens,ElisabethK;Novotny,Paul;Price,Katharine;Salayi,Marcia;Roeker,Lindsey;Peethambaram,Prema;Jatoi,Aminah
- 通讯作者:Jatoi,Aminah
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aminah Jatoi其他文献
Aminah Jatoi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aminah Jatoi', 18)}}的其他基金
Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs
患有严重疾病的老年性和性别少数患者:建立项目以确定和满足需求
- 批准号:
10684915 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Older Sexual and Gender Minority Patients with Serious Illness: Program-Building to Identify and Address Needs
患有严重疾病的老年性和性别少数患者:建立项目以确定和满足需求
- 批准号:
10523705 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients
缓解非裔美国人和其他癌症患者的 EGFR 抑制剂皮疹
- 批准号:
10599238 - 财政年份:2017
- 资助金额:
$ 19.49万 - 项目类别:
Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients
缓解非裔美国人和其他癌症患者的 EGFR 抑制剂皮疹
- 批准号:
9274475 - 财政年份:2017
- 资助金额:
$ 19.49万 - 项目类别:
Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients
缓解非裔美国人和其他癌症患者的 EGFR 抑制剂皮疹
- 批准号:
9934138 - 财政年份:2017
- 资助金额:
$ 19.49万 - 项目类别:
Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients
缓解非裔美国人和其他癌症患者的 EGFR 抑制剂皮疹
- 批准号:
10381450 - 财政年份:2017
- 资助金额:
$ 19.49万 - 项目类别:
Rash from EGFR Inhibitors: Characterization & Palliation of a Symptom Cluster
EGFR 抑制剂引起的皮疹:特征
- 批准号:
7503895 - 财政年份:2008
- 资助金额:
$ 19.49万 - 项目类别:
Rash from EGFR Inhibitors: Characterization & Palliation of a Symptom Cluster
EGFR 抑制剂引起的皮疹:特征
- 批准号:
7666950 - 财政年份:2008
- 资助金额:
$ 19.49万 - 项目类别:
Mentoring and Research in Cancer Palliative Care
癌症姑息治疗的指导和研究
- 批准号:
8126204 - 财政年份:2008
- 资助金额:
$ 19.49万 - 项目类别:
Mentoring and Research in Cancer Palliative Care
癌症姑息治疗的指导和研究
- 批准号:
7525230 - 财政年份:2008
- 资助金额:
$ 19.49万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 19.49万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 19.49万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 19.49万 - 项目类别:














{{item.name}}会员




